Latest GSK News & Updates

See the latest news and media coverage for GSK. We track all announcements, press releases, and industry mentions in real time, all in one place.

GSK

Biopharmaceutical company developing medicines and vaccines

gsk.com

Headquarters: London, United Kingdom
Company type: Public company
Number of employees: 90,000+
Industry: Pharmaceuticals

Last updated Today

Latest news about GSK

In short: GSK gained FDA approval for a lung cancer drug, launched a £1.9 billion savings plan, and advanced several late-stage clinical trials.

Company announcements

Yesterday GSK

GSK acquires T cell engager from Chimagen for up to $750 million

The asset targets multiple myeloma and is expected to enter phase I trials in 2027.

September 13 GSK

GSK presents positive trial data to expand Jideytro

The ARROS-1 trial shows high response rates in lung cancer patients, supporting a US FDA submission this year.

September 13 GSK

GSK announces positive survival data for lung cancer drug Ris-Rez

Ris-Rez reduced death risk by 54% in Chinese patients with relapsed small cell lung cancer. GSK licenses rights outside China.

September 10 GSK

GSK vaccine receives Japanese regulatory approval

Japan's Ministry of Health, Labour and Welfare approved a new prefilled syringe presentation of one of the company's vaccines.

Media coverage

Yesterday Börsvärlden

GSK upgraded to buy by Berenberg – target price raised to 22 pounds

Berenberg upgrades pharmaceutical company Glaxosmithkline, GSK, from hold to buy and raises the target price to 22 from 20 pounds, representing approximately 24 percent upside.

September 14 Pharmaceutical Executive

Roundup: GSK Acquires Trispecific T Cell-Engager from Chimagen, Sanofi & Cheplapharm Form Strategic Partnership

GSK agrees to acquire a trispecific T cell engager for multiple myeloma from Chimagen Biosciences, while Sanofi is offloading 20 mature medicines and three manufacturing...

September 14 Ad hoc news

GSK stock heads into the open after a 4.6% jump on trial data

At the close on September 14, 2026, GSK stock gained 4.63% in London to 1,854.5 pence, outperforming the FTSE 100 as positive lung cancer trial...

September 14 International Business Times

GSK Shares Jump 3.83% as Twin Lung Cancer Drug Trial Wins Reinforce Its Growing Oncology Pipeline Bet

GSK shares climbed after the company reported encouraging clinical trial results for two lung cancer treatments, strengthening its oncology strategy despite mixed analyst views on...

Never miss news about GSK

Track GSK and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

GSK competitors & trending companies

Browse news for competitors to GSK and other trending companies.